Azole susceptibility and transcriptome profiling in Candida albicans mitochondrial electron transport chain complex I mutants

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 1, 2013, Pages 532-542

  Sun, Nuo ^a   Fonzi, William ^a   Chen, Hui ^a   She, Xiaodong ^a,b   Zhang, Lulu ^a,c   Zhang, Lixin ^d   Calderone, Richard ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b INSTITUTE OF DERMATOLOGY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ACETYL COENZYME A ACETYLTRANSFERASE; ANTIMYCIN A1; CDR1 PROTEIN; CDR2 PROTEIN; ERGOSTEROL; FLUCONAZOLE; GLYCEROL; GLYOXYLIC ACID; MITOCHONDRIAL ELECTRON TRANSPORT CHAIN COMPLEX 1; OLIGOMYCIN; PIERICIDIN A; PYRROLE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOGENESIS; CANDIDA ALBICANS; CELL ENERGY; CELL RESPIRATION; CONTROLLED STUDY; DOWN REGULATION; ELECTRON TRANSPORT; FATTY ACID OXIDATION; FUNGUS GROWTH; FUNGUS ISOLATION; GENE EXPRESSION PROFILING; GENE REPLICATION; GENETIC TRANSCRIPTION; LIPOGENESIS; MITOCHONDRIAL ENERGY TRANSFER; PEROXISOME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TRANSPORT; RNA SEQUENCE;

ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX I; ERGOSTEROL; FLUCONAZOLE; FUNGAL PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, FUNGAL; MICROBIAL SENSITIVITY TESTS; MITOCHONDRIA; MUTATION; PEROXISOMES; TRANSCRIPTOME;

EID: 84872026338     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01520-12     Document Type: Article

References (46)

1. Pfaller MA, Andes D, Arendrup MC, Diekema DJ, Espinel-Ingroff A, Alexander BD, Brown SD, Chaturvedi V, Fowler CL, Ghannoum MA, Johnson EM, Knapp CC, Motyl MR, Ostrosky-Zeichner L, Walsh TJ. 2011. Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn. Microbiol. Infect. Dis. 70:330-343.
2. Perlin DS. 2011. Current perspectives on echinocandin class drugs. Future Microbiol. 6:441-457.
3. Finkel JS, Mitchell AP. 2011. Genetic control of Candida albicans biofilm development. Nat. Rev. Microbiol. 9:109-118.
4. Pao SS, Paulsen IT, Saier MH, Jr. 1998. Major facilitator superfamily. Microbiol. Mol. Biol. Rev. 62:1-34.
5. Coste AT, Karababa M, Ischer F, Bille J, Sanglard D. 2004. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot. Cell 3:1639-1652.
6. Dunkel N, Blass J, Rogers PD, Morschhauser J. 2008. Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains. Mol. Microbiol. 69:827-840.
7. Batova M, Borecka-Melkusova S, Simockova M, Dzugasova V, Goffa E, Subik J. 2008. Functional characterization of the CgPGS1 gene reveals a link between mitochondrial phospholipid homeostasis and drug resistance in Candida glabrata. Curr. Genet. 53:313-322.
8. Bouchara JP, Zouhair R, Le Boudouil S, Renier G, Filmon R, Chabasse D, Hallet JN, Defontaine A. 2000. In-vivo selection of an azole-resistant petite mutant of Candida glabrata. J. Med. Microbiol. 49:977-984.
9. Ferrari S, Sanguinetti M, De Bernardis F, Torelli R, Posteraro B, Vandeputte P, Sanglard D. 2011. Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice. Antimicrob. Agents Chemother. 55:1852-1860.
10. Kaur R, Castano I, Cormack BP. 2004. Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria. Antimicrob. Agents Chemother. 48:1600-1613.
11. Sanglard D, Ischer F, Bille J. 2001. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob. Agents Chemother. 45:1174-1183.
12. Vandeputte P, Tronchin G, Rocher F, Renier G, Berges T, Chabasse D, Bouchara J-P. 2009. Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth. Antimicrob. Agents Chemother. 53:3034-3041.
13. Hallstrom TC, Moye-Rowley WS. 2000. Multiple signals from dysfunctional mitochondria activate the pleiotropic drug resistance pathway in Saccharomyces cerevisiae. J. Biol. Chem. 275:37347-37356.
14. Cheng S, Clancy CJ, Nguyen KT, Clapp W, Nguyen MH. 2007. A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole. Antimicrob. Agents Chemother. 51:1855-1858.
15. Aoki S, Ito-Kuwa S, Nakamura K, Nakamura Y. 2005. Cell biology of respiration-deficient mutants of Candida albicans. Nihon Ishinkin Gakkai Zasshi 46:243-247.
16. Aoki S, Ito-Kuwa S, Nakamura Y, Masuhara T. 1990. Comparative pathogenicity of a wild-type strain and respiratory mutants of Candida albicans in mice. Zentralbl. Bakteriol. 273:332-343.
17. Roth-Ben Arie Z, Altboum Z, Berdicevsky I, Segal E. 1998. Isolation of a petite mutant from a histidine auxotroph of Candida albicans and its characterization. Mycopathologia 141:127-135.
18. Bambach A, Fernandes MP, Ghosh A, Kruppa M, Alex D, Li D, Fonzi WA, Chauhan N, Sun N, Agrellos OA, Vercesi AE, Rolfes RJ, Calderone R. 2009. Goa1p of Candida albicans localizes to the mitochondria during stress and is required for mitochondrial function and virulence. Eukaryot. Cell 8:1706-1720.
19. Li D, Chen H, Florentino A, Alex D, Sikorski P, Fonzi WA, Calderone R. 2011. Enzymatic dysfunction of mitochondrial complex I of the Candida albicans goa1 mutant is associated with increased reactive oxidants and cell death. Eukaryot. Cell 10:672-682.
20. McDonough JA, Bhattacherjee V, Sadlon T, Hostetter MK. 2002. Involvement of Candida albicans NADH dehydrogenase complex I in filamentation. Fungal Genet. Biol. 36:117-127.
21. Vellucci VF, Gygax SE, Hostetter MK. 2007. Involvement of Candida albicans pyruvate dehydrogenase complex protein X (Pdx1) in filamentation. Fungal Genet. Biol. 44:979-990.
22. Fendel U, Tocilescu MA, Kerscher S, Brandt U. 2008. Exploring the inhibitor binding pocket of respiratory complex I. Biochim. Biophys. Acta 1777:660-665.
23. Okun JG, Lummen P, Brandt U. 1999. Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH: ubiquinone oxidoreductase). J. Biol. Chem. 274:2625-2630.
24. Noble SM, French S, Kohn LA, Chen V, Johnson AD. 2010. Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat. Genet. 42:590-598.
25. Cowen LE, Lindquist S. 2005. Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science 309:2185-2189.
26. Karababa M, Coste AT, Rognon B, Bille J, Sanglard D. 2004. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob. Agents Chemother. 48:3064-3079.
27. Tsai HF, Sammons LR, Zhang X, Suffis SD, Su Q, Myers TG, Marr KA, Bennett JE. 2010. Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates. Antimicrob. Agents Chemother. 54:3308-3317.
28. Tsao S, Rahkhoodaee F, Raymond M. 2009. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance. Antimicrob. Agents Chemother. 53:1344-1352.
29. Fagarasanu A, Mast FD, Knoblach B, Rachubinski RA. 2010. Molecular mechanisms of organelle inheritance: lessons from peroxisomes in yeast. Nat. Rev. Mol. Cell Biol. 11:644-654.
30. Neuspiel M, Schauss AC, Braschi E, Zunino R, Rippstein P, Rachubinski RA, Andrade-Navarro MA, McBride HM. 2008. Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. Curr. Biol. 18:102-108.
31. Strijbis K, Distel B. 2010. Intracellular acetyl unit transport in fungal carbon metabolism. Eukaryot. Cell 9:1809-1815.
32. Strijbis K, van Roermund CW, van den Burg J, van den Berg M, Hardy GP, Wanders RJ, Distel B. 2010. Contributions of carnitine acetyltransferases to intracellular acetyl unit transport in Candida albicans. J. Biol. Chem. 285:24335-24346.
33. van Roermund CW, Hettema EH, van den Berg M, Tabak HF, Wanders RJ. 1999. Molecular characterization of carnitine-dependent transport of acetyl-CoA from peroxisomes to mitochondria in Saccharomyces cerevisiae and identification of a plasma membrane carnitine transporter, Agp2p. EMBO J. 18:5843-5852.
34. Strijbis K, van Roermund CW, Visser WF, Mol EC, van den Burg J, MacCallum DM, Odds FC, Paramonova E, Krom BP, Distel B. 2008. Carnitine-dependent transport of acetyl coenzyme A in Candida albicans is essential for growth on nonfermentable carbon sources and contributes to biofilm formation. Eukaryot. Cell 7:610-618.
35. Cabezón V, Llama-Palacios A, Nombela C, Monteoliva L, Gil C. 2009. Analysis of Candida albicans plasma membrane proteome. Proteomics 9:4770-4786.
36. Lorenz MC, Bender JA, Fink GR. 2004. Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot. Cell 3:1076-1087.
37. Lorenz MC, Fink GR. 2001. The glyoxylate cycle is required for fungal virulence. Nature 412:83-86.
38. Ramírez MA, Lorenz MC. 2007. Mutations in alternative carbon utilization pathways in Candida albicans attenuate virulence and confer pleiotropic phenotypes. Eukaryot. Cell 6:280-290.
39. Harner M, Korner C, Walther D, Mokranjac D, Kaesmacher J, Welsch U, Griffith J, Mann M, Reggiori F, Neupert W. 2011. The mitochondrial contact site complex, a determinant of mitochondrial architecture.EMBO J. 30:4356-4370.
40. Paul S, Schmidt JA, Moye-Rowley WS. 2011. Regulation of the CgPdr1 transcription factor from the pathogen Candida glabrata. Eukaryot. Cell 10:187-197.
41. Coste AT, Ramsdale M, Ischer F, Sanglard D. 2008. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae. Microbiology 154:1491-1501.
42. Gohil VM, Sheth SA, Nilsson R, Wojtovich AP, Lee JH, Perocchi F, Chen W, Clish CB, Ayata C, Brookes PS, Mootha VK. 2010. Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis. Nat. Biotechnol. 28:249-255.
43. Moreira PI, Oliveira CR. 2011. Mitochondria as potential targets in antidiabetic therapy. Handb. Exp. Pharmacol. 203:331-356.
44. Smith RA, Hartley RC, Murphy MP. 2011. Mitochondria-targeted small molecule therapeutics and probes. Antioxid. Redox Signal. 15: 3021-3038.
45. Szewczyk A, Wojtczak L. 2002. Mitochondria as a pharmacological target. Pharmacol. Rev. 54:101-127.
46. Shingu-Vazquez M, Traven A. 2011. Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy. Eukaryot. Cell 10:1376-1383.